PTGER2 and diabetes mellitus: These experiments link PGE2-EP2 signaling more directly to the inflammatory activation of hMG under conditions modeling aspects of systemic diabetes, yet the partial reductions with antagonist treatment enforce the notion that there are many distinct proinflammatory pathways active in such conditions in addition to the effects of PGE2.